0 items USD 0.00Search
- Did you mean
- chronic%lymphocytic%leukemia
Your search for "Chronic%2520lymphocytic%2520leukemia" gave back 307884 results.
Market Analysis and Insights: Global Chronic Lymphocytic Leukemia Therapeutics Market The global Chronic Lymphocytic Leukemia Therapeutics market is...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The “Chronic Lymphocytic Leukemia Therapeutics Industry Forecast” looks at past sales and reviews total world Chronic Lymphocytic Leukemia...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Treatment options for chronic lymphocytic leukemia (CLL) vary greatly, depending on the person’s age, the disease risk group, and the reason for...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Treatment options for chronic lymphocytic leukemia (CLL) vary greatly, depending on the person’s age, the disease risk group, and the reason for...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Chronic Lymphocytic Leukemia (CLL) is a type of hematological malignancy marked by excessive proliferation of abnormal white blood cells. CLL...
Catalog:
LPI
February 2023
Price: USD 3,660.00
According to our Publisher latest study, the global Chronic Lymphocytic Leukemia Therapeutics market size was valued at USD 8654.7 million in 2022...
Catalog:
GIR
February 2023
Price: USD 3,480.00
Chronic Lymphocytic Leukemia (CLL) is a type of hematological malignancy marked by excessive proliferation of abnormal white blood cells. CLL...
Catalog:
GIR
February 2023
Price: USD 3,480.00
Cytotoxic T Lymphocyte Protein 4 - Pipeline Review, H2 2019 Summary According to the recently published report 'Cytotoxic T Lymphocyte Protein 4...
Catalog:
Global Markets Direct
November 2019
Price: USD 3,500.00
Chronic lymphocytic leukemia is a type of cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell). Chronic...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Chronic Lymphocytic Leukemia (CLL) is a type of hematological malignancy marked by excessive proliferation of abnormal white blood cells. CLL...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Treatment options for chronic lymphocytic leukemia (CLL) vary greatly, depending on the person’s age, the disease risk group, and the reason for...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Highlights The global Chronic Lymphocytic Leukemia Therapeutics market was valued at US$ 9390.9 million in 2022 and is anticipated to reach US$ 17350...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Tyrosine Protein Kinase SYK (Spleen Tyrosine Kinase or p72 Syk or SYK or EC 2.7.10.2) - Pipeline Review, H2 2018 Summary Tyrosine Protein Kinase SYK...
Catalog:
Global Markets Direct
November 2018
Price: USD 3,500.00
Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare...
Catalog:
Global Markets Direct
October 2021
Price: USD 2,500.00
Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog:
Global Markets Direct
May 2018
Price: USD 2,000.00
